Squadron Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Squadron Capital Management LLC
CRD #334296
SEC #801-136915
CIK #0002050709, 0001719228
AUM 385.7 M (2026-06-29)
Employees 4 (75% Investors, 0% Brokers)
Phone214-478-3862
Address1211 West 22nd Street
Oak Brook, IL 60523
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
4003202401608002010201520212027
CIK Period
0002050709 0001719228
Sector Form 13F Holdings Value ($M)
Camp Nine Inc 59.0
UNUM Therapeutics Inc 30.3
Kodiak Sciences Inc 14.5
Abivax Sa 14.5
Edgewise Therapeutics Inc 11.0
Zentalis Pharmaceuticals Inc 9.4
Nektar Therapeutics 9.0
Adlai Nortye Ltd 8.8
Relay Therapeutics Inc 8.2
MAZE Therapeutics Inc 7.7
IDEAYA Biosciences Inc 7.5
Scynexis Inc 7.0
C4 Therapeutics Inc 5.9
Inhibikase Therapeutics Inc 5.9
Neuralstem Inc 5.2
Eupraxia Pharmaceuticals Inc 4.9
GH Research PLC 4.6
Karyopharm Therapeutics Inc 4.2
Promis Neurosciences Inc 4.1
Marathon Bar Corp 3.6
Inventiva Sa 3.0
ALX Oncology Holdings Inc 2.9
Context Therapeutics Inc 2.9
NextCure Inc 2.8
Arrivent Biopharma Inc 2.5
Sol-Gel Technologies Ltd 2.5
Pasithea Therapeutics Corp 1.6
Onconova Therapeutics Inc 0.9
AMHN Inc 0.8
 
 
Prev | Page 1 | Next
Type Form D Funds Date Sold AUM
HF Squadron Fund LP [2024-12-17] 8.1 M 29.8 M
Filed 2024-12-30 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Squadron Master Fund LP [2024-12-17] 136.9 M 385.7 M
Filed 2025-10-29 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $360,135 · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 2 385.7
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 2 385.7
By Discretionary
Discretionary 2 385.7
Non-Discretionary 0 0.0
Total 2 385.7
By Non-United States Persons
Non-United States Persons 258.5
United States Persons 127.2
Total 2 385.7
Form D Directors Role # Filings # Firms 2011 - 2026
Matthew Sesterhenn Executive Officer 3 2
Squadron Capital Management LLC Executive Officer, Promoter 3 2
William Blank Executive Officer 2 2
Blank William Executive Officer 2 2
Squadron Partners LLC Executive Officer, Promoter 2 1
EDGAR Form CIK 2011 - 2026
3 [0001719228]
4 [0001719228]
5 [0001719228]
SC 13D [0001719228]
SC 13G [0001719228]
13F-HR [0002050709]
SC 13G [0002050709]
Form 13D/13G Filer Form 13D/13G Subject Filed
Squadron Capital Management LLC Inmed Pharmaceuticals Inc [2026-05-27]
Squadron Capital Management LLC C4 Therapeutics Inc [2026-05-19]
Squadron Capital Management LLC Scynexis Inc [2026-04-08]
Squadron Capital Management LLC Aprea Therapeutics Inc [2026-04-07]
Squadron Capital Management LLC Zentalis Pharmaceuticals Inc [2026-03-03]
Squadron Capital Management LLC Lipocine Inc [2025-12-23]
Squadron Capital Management LLC Pasithea Therapeutics Corp [2025-12-05]
Squadron Capital Management LLC NextCure Inc [2025-10-24]
Squadron Capital Management LLC Spruce Biosciences Inc [2025-10-15]
Squadron Capital Management LLC Palisade Bio Inc [2025-10-08]
View All
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund
LEI254900NL1HGIPXX5C383
Form 3/4/5 Subject 2011 - 2026
Squadron Capital LLC
Alphatec Holdings Inc
Orthopediatrics Corp
Squadron Capital Holdings LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Alphatec Holdings Inc ATEC
Common Stock
2025-12-09 Sell 28,834 $21.03 606,379
Alphatec Holdings Inc ATEC
Common Stock
2025-12-08 Sell 221,166 $21.20 4,688,719
Alphatec Holdings Inc ATEC
Common Stock
2025-11-24 Sell 250,000 $20.62 5,155,000
Alphatec Holdings Inc ATEC
Common Stock
2025-11-12 Sell 250,000 $20.80 5,200,000
Orthopediatrics Corp KIDS
Common Stock
2022-09-20 Option exercise 1,525,000 $0.00
Orthopediatrics Corp KIDS
Warrants (right to buy) · derivative
2022-09-20 Option exercise 1,525,000 $0.00
Orthopediatrics Corp KIDS
Warrants (right to buy) · derivative
2022-08-11 Buy 1,525,000 $55.00 83,875,000
Orthopediatrics Corp KIDS
Common Stock
2020-06-19 Option exercise 1,340 $30.97 41,500
Orthopediatrics Corp KIDS
Stock Option (Right to Buy) · derivative
2020-06-19 Option exercise 1,340 $30.97 41,500
Orthopediatrics Corp KIDS
Series A Convertible Preferred Stock · derivative
2017-10-16 Conversion 1,000,000 $0.00
Orthopediatrics Corp KIDS
Series B Convertible Preferred Stock · derivative
2017-10-16 Conversion 4,157,960 $0.00
Orthopediatrics Corp KIDS
Common Stock
2017-10-16 Conversion 3,455,833
Orthopediatrics Corp KIDS
Common Stock
2017-10-16 Conversion 1,920,062
Comparable Firms State AUM
India Capital Management Limited
395.3 M
ORSO Partners LP
CA 387.5 M
Braeswood Carbon Management LLC
CA 387.3 M
Otus Capital Management Limited
387.0 M
Camac Partners LLC
386.6 M
Brightlight Capital Management LP
CT 385.8 M
Atlantic Investment Management Inc
NY 384.0 M
Clearshares LLC
FL 382.5 M
Siena Capital Partners GP LLC
IL 379.3 M
Breyta Capital Partners LP
NY 377.6 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com